Anne Hedengran Nagstrup

Anne Hedengran Nagstrup

Senior Researcher, ph.d.


Publication year:
  1. 2023
  2. Published

    Controversial preservation of eye drops: The toxicity of benzalkonium chloride

    Nagstrup, Anne Hedengran & Kolko, Miriam, 2023, In: Adverse Drug Reaction Bulletin. 338, 1, p. 1311-1314

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment

    Kolko, Miriam, Gazzard, G., Baudouin, C., Beier, S., Brignole-Baudouin, F., Cvenkel, B., Fineide, F., Nagstrup, Anne Hedengran, Hommer, A., Jespersen, E., Messmer, E. M., Murthy, R., Sullivan, A. G., Tatham, A. J., Utheim, T. P., Vittrup, M. & Sullivan, D. A., 2023, In: Ocular Surface. 29, p. 456-468

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The molecular aspect of anti-glaucomatous eye drops: are we harming our patients?

    Nagstrup, Anne Hedengran & Kolko, Miriam, 2023, In: Molecular Aspects of Medicine. 93, 10 p., 101195.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    The use of benzalkonium chloride in topical glaucoma treatment

    Nagstrup, Anne Hedengran, 2023, In: Acta Ophthalmologica. 101, S278, p. 3-21

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2022
  7. Published

    Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement

    Thein, A. S., Nagstrup, Anne Hedengran, Azuara-Blanco, A., Arita, R., Cvenkel, B., Gazzard, G., Heegaard, Steffen, de Paiva, C. S., Petrovski, G., Prokosch-Willing, V., Utheim, T. P., Virgili, G. & Kolko, Miriam, 2022, In: American Journal of Ophthalmology. 241, p. 190-197

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival

    Freiberg, Josefine, Nagstrup, Anne Hedengran, Heegaard, Steffen, Petrovski, G., Jacobsen, Jette, Cvenkel, B. & Kolko, Miriam, 2022, In: Journal of Clinical Medicine. 11, 11, 3137.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published
  10. Published

    IFNγ reduces viability in human conjunctival goblet cells in vitro

    Hansen, Pernille May, Nagstrup, Anne Hedengran, Thyssen, Jacob Pontoppidan, Heegaard, Steffen & Kolko, Miriam, 2022, In: Acta Ophthalmologica. 100, S267

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  11. Published

    IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

    Hansen, Pernille May, Tollenaere, M. A. X., Nagstrup, Anne Hedengran, Heegaard, Steffen, Amoudruz, P., Røpke, M., Thyssen, Jacob Pontoppidan, Kolko, Miriam & Norsgaard, H., 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 8, p. 2555-2558

    Research output: Contribution to journalLetterResearchpeer-review

  12. Published

    Interleukin (IL)-13 and IL-4 promote proliferation and mRNA expression of MUC2 and MUC5AC in primary human conjunctival goblet cells

    Tollenaere, M. A. X., Hansen, Pernille May, Nagstrup, Anne Hedengran, Heegaard, Steffen, Roepke, M., Schneider, S., Norsgaard, H., Thyssen, Jacob Pontoppidan & Kolko, Miriam, 2022, In: British Journal of Dermatology. 186, 4, p. E146-E146 1 p., 620.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

Previous 1 2 Next

ID: 233514402